Teleflex (NYSE:TFX) - Share price, News & Analysis

TFX fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	5/6
Financial Health	5/6
Dividends	0/6

TFX Stock Overview

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

Rewards

Trading at 39.2% below our estimate of its fair value

Earnings are forecast to grow 4.08% per year

Earnings grew by 74% over the past year

Risk Analysis

No risks detected for TFX from our risk checks.

Teleflex Competitors

Abbott Laboratories

NYSE:ABT

US$192.4b

Medtronic

NYSE:MDT

US$137.7b

Stryker

NYSE:SYK

US$88.2b

Intuitive Surgical

NasdaqGS:ISRG

US$80.3b

Price History & Performance

Summary of all time highs, changes and price drops for Teleflex
Historical stock prices
Current Share Price	US$278.46
52 Week High	US$428.36
52 Week Low	US$256.77
Beta	1.13
1 Month Change	-17.28%
3 Month Change	-12.25%
1 Year Change	-29.15%
3 Year Change	-5.93%
5 Year Change	41.65%
Change since IPO	2,583.95%

Recent News & Updates

May 02

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Teleflex Incorporated ( NYSE:TFX ) received a lot of attention from a substantial price movement on the NYSE over the...

Shareholder Returns

	TFX	US Medical Equipment	US Market
7D	3.3%	-2.3%	-2.5%
1Y	-29.1%	-15.6%	-10.4%

Return vs Industry: TFX underperformed the US Medical Equipment industry which returned -15.6% over the past year.

Return vs Market: TFX underperformed the US Market which returned -10.4% over the past year.

Price Volatility

Is TFX's price volatile compared to industry and market?
TFX volatility
TFX Average Weekly Movement	5.1%
Medical Equipment Industry Average Movement	10.4%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.7%
10% least volatile stocks in US Market	2.8%

Stable Share Price: TFX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1943	14,000	Liam Kelly	https://www.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.

Teleflex Fundamentals Summary

How do Teleflex's earnings and revenue compare to its market cap?
TFX fundamental statistics
Market Cap	US$13.06b
Earnings (TTM)	US$487.62m
Revenue (TTM)	US$2.82b

26.8x

P/E Ratio

4.6x

P/S Ratio

Is TFX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
TFX income statement (TTM)
Revenue	US$2.82b
Cost of Revenue	US$1.27b
Gross Profit	US$1.55b
Other Expenses	US$1.06b
Earnings	US$487.62m

Last Reported Earnings

Mar 27, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	10.40
Gross Margin	55.04%
Net Profit Margin	17.31%
Debt/Equity Ratio	48.8%

How did TFX perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

13%

Payout Ratio

Valuation

Is Teleflex undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

39.2%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: TFX ($278.46) is trading below our estimate of fair value ($458.23)

Significantly Below Fair Value: TFX is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: TFX is good value based on its PE Ratio (26.8x) compared to the US Medical Equipment industry average (35x).

PE vs Market: TFX is poor value based on its PE Ratio (26.8x) compared to the US market (15.5x).

Price to Earnings Growth Ratio

PEG Ratio: TFX is poor value based on its PEG Ratio (6.6x)

Price to Book Ratio

PB vs Industry: TFX is overvalued based on its PB Ratio (3.4x) compared to the US Medical Equipment industry average (2.5x).

Future Growth

How is Teleflex forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

4.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TFX's forecast earnings growth (4.1% per year) is above the savings rate (1.9%).

Earnings vs Market: TFX's earnings (4.1% per year) are forecast to grow slower than the US market (12.6% per year).

High Growth Earnings: TFX's earnings are forecast to grow, but not significantly.

Revenue vs Market: TFX's revenue (5.6% per year) is forecast to grow slower than the US market (8% per year).

High Growth Revenue: TFX's revenue (5.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TFX's Return on Equity is forecast to be low in 3 years time (13.7%).

Past Performance

How has Teleflex performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

20.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TFX has high quality earnings.

Growing Profit Margin: TFX's current net profit margins (17.3%) are higher than last year (11%).

Past Earnings Growth Analysis

Earnings Trend: TFX's earnings have grown significantly by 20.8% per year over the past 5 years.

Accelerating Growth: TFX's earnings growth over the past year (74%) exceeds its 5-year average (20.8% per year).

Earnings vs Industry: TFX earnings growth over the past year (74%) exceeded the Medical Equipment industry 16.4%.

Return on Equity

High ROE: TFX's Return on Equity (12.8%) is considered low.

Financial Health

How is Teleflex's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: TFX's short term assets ($1.5B) exceed its short term liabilities ($656.2M).

Long Term Liabilities: TFX's short term assets ($1.5B) do not cover its long term liabilities ($2.4B).

Debt to Equity History and Analysis

Debt Level: TFX's net debt to equity ratio (35.8%) is considered satisfactory.

Reducing Debt: TFX's debt to equity ratio has reduced from 91.7% to 48.8% over the past 5 years.

Debt Coverage: TFX's debt is well covered by operating cash flow (32.6%).

Interest Coverage: TFX's interest payments on its debt are well covered by EBIT (11.2x coverage).

Balance Sheet

Dividend

What is Teleflex current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

0.49%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: TFX's dividend (0.49%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.54%).

High Dividend: TFX's dividend (0.49%) is low compared to the top 25% of dividend payers in the US market (4.05%).

Stability and Growth of Payments

Stable Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.

Earnings Payout to Shareholders

Earnings Coverage: TFX is not paying a notable dividend for the US market.

Cash Payout to Shareholders

Cash Flow Coverage: TFX is not paying a notable dividend for the US market.

Next Steps

Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

5.0yrs

Average management tenure

CEO

Liam Kelly (54 yo)

6yrs

Tenure

US$8,673,634

Compensation

Mr. Liam J. Kelly has been Chief Executive Officer at Teleflex Incorporated since January 01, 2018 and has been its Director since May 4, 2018. He serves as Independent Director of Enovis Corporation (form...

CEO Compensation Analysis

Compensation vs Market: Liam's total compensation ($USD8.67M) is below average for companies of similar size in the US market ($USD13.26M).

Compensation vs Earnings: Liam's compensation has increased by more than 20% in the past year.

Leadership Team

Experienced Management: TFX's management team is seasoned and experienced (5 years average tenure).

Board Members

Experienced Board: TFX's board of directors are considered experienced (5.3 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/15 00:00
End of Day Share Price	2022/05/13 00:00
Earnings	2022/03/27
Annual Earnings	2021/12/31